- Home
- DYN vs IOSP Comparison
DYN vs IOSP Comparison
Compare DYN & IOSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- IOSP
- Stock Information
- Founded
- DYN 1984
- IOSP 1938
- Country
- DYN United States
- IOSP United States
- Employees
- DYN N/A
- IOSP N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- IOSP Major Chemicals
- Sector
- DYN Health Care
- IOSP Industrials
- Exchange
- DYN Nasdaq
- IOSP Nasdaq
- Market Cap
- DYN 2.6B
- IOSP 2.6B
- IPO Year
- DYN 2020
- IOSP 1998
- Fundamental
- Price
- DYN $14.01
- IOSP $103.36
- Analyst Decision
- DYN Strong Buy
- IOSP
- Analyst Count
- DYN 10
- IOSP 0
- Target Price
- DYN $50.78
- IOSP N/A
- AVG Volume (30 Days)
- DYN 2.1M
- IOSP 138.5K
- Earning Date
- DYN 03-04-2025
- IOSP 02-18-2025
- Dividend Yield
- DYN N/A
- IOSP 1.50%
- EPS Growth
- DYN N/A
- IOSP N/A
- EPS
- DYN N/A
- IOSP 1.42
- Revenue
- DYN N/A
- IOSP $1,845,400,000.00
- Revenue This Year
- DYN N/A
- IOSP $4.86
- Revenue Next Year
- DYN N/A
- IOSP $5.17
- P/E Ratio
- DYN N/A
- IOSP $72.66
- Revenue Growth
- DYN N/A
- IOSP N/A
- 52 Week Low
- DYN $13.07
- IOSP $99.49
- 52 Week High
- DYN $47.45
- IOSP $133.71
- Technical
- Relative Strength Index (RSI)
- DYN 37.85
- IOSP 34.85
- Support Level
- DYN $13.59
- IOSP $99.49
- Resistance Level
- DYN $14.50
- IOSP $112.74
- Average True Range (ATR)
- DYN 0.98
- IOSP 3.21
- MACD
- DYN 0.32
- IOSP -1.11
- Stochastic Oscillator
- DYN 22.90
- IOSP 22.87
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About IOSP Innospec Inc.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.